<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Diagnosis of Viral Disease | Medical Virology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts - Inter for UI, Source Serif for reading -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- KaTeX for Math rendering -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js" onload="renderMathInElement(document.body, {
        delimiters: [
            {left: '$$', right: '$$', display: true},
            {left: '$', right: '$', display: false}
        ]
    });"></script>
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
</head>
<body>
    <!-- Skip Link for Accessibility -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Theme Toggle (Fixed Position) -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Reading Progress Bar -->
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                
                <!-- TOP NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-02-cultivation.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="topic-04-vaccines-antivirals.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 75%;"></div>
                        </div>
                        <span class="progress-text">Topic 3 of 4</span>
                    </div>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span>üß™</span>
                        <span>Topic 03</span>
                    </div>
                    <h1 class="document-title">Diagnosis of Viral Disease</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Chapter 3</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>20 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- START: introduction -->
                    <section class="content-section" id="introduction">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Collection of Specimens for Virology
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Specimens should be collected during the acute stage of illness when viruses are shed in large numbers. The appropriate specimens collected for various viral infections are listed in Table 3.1. Specimens such as swabs or tissues should not be allowed to dry before reaching the laboratory. Such specimens should be placed in about 3‚Äì4ml of a viral transport medium (VTM) so that the viruses do not die due to dehydration. The VTM has a buffering system to maintain the pH between 7.2 and 7.4, a low concentration of protective proteins and antibiotics to inhibit bacterial and fungal contaminants. Various types of VTM are commercially available.</p>

                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">‚öóÔ∏è</span>
                                    <h4 class="callout-title">Viral transport medium (VTM) Recipe</h4>
                                </div>
                                <div class="callout-content">
                                    <p>A simple VTM can be prepared as follows:</p>
                                    <ul class="enhanced-list">
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Hank's balanced salt solution</strong> : 100 ml</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Foetal bovine serum</strong> : 2 ml</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Gentamicin</strong> : 10 mg</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Amphoterin B</strong> : 50 Œºg</span>
                                        </li>
                                    </ul>
                                </div>
                            </div>

                            <h3>Commonly used specimens</h3>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Throat swab:</strong> Swab the tonsillar area and the posterior wall of the pharynx with a cotton tipped sterile swab. Place it in 3‚Äì4ml of VTM and send it to the laboratory immediately.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Respiratory aspiration:</strong> Collect the respiratory secretions into a plastic disposable suction aspirator using a fine gauge rubber catheter. In babies, pass it through the nose, and in adults through the posterior pharynx.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Nasal washings:</strong> Instill about 5 ml saline into each nostril and collect into a screw-capped bottle. Alternatively, a cotton swab may be used. It should be left in the nostril for 15‚Äì20 seconds and rotated firmly to collect the newly formed secretions.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Mucous membrane swabs:</strong> Swab the mouth, lips or genital areas and put into VTM.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Conjunctival swabs:</strong> Collect these swabs using dry cotton swabs. Roll a dry cotton swab gently along the lower conjunctival surface. Collect into VTM.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Vesicle fluid:</strong> Aspirate several vesicles using a tuberculin syringe and a 15 gauge needle. If possible, choose fresh, plump vesicles. Send the vesicle fluid in a sterile container to the laboratory.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Cerebrospinal, pericardial and pleural fluid:</strong> Place about 1 ml of fluid in a dry, sterile container.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Saliva, urine, stool:</strong> These specimens should be collected in sterile containers. Rectal swab may be used if stool cannot be obtained.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Tissue:</strong> It should be collected from an appropriate part of the organ, placed in a sterile container containing 3‚Äì4 ml of VTM and kept at 4¬∞C until it reaches the virology laboratory.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Blood:</strong> Collect 10 ml of blood in a sterile container containing heparin, EDTA or citrate. For serology, collect blood in a plain sterile tube.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Postmortem specimens:</strong> These should be collected from the suspected sites of disease and transported to the laboratory as soon as possible.</span>
                                </li>
                            </ol>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-caption">Table 3.1 Specimens for diagnosis of viral infections</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table comparison-table">
                                        <thead>
                                            <tr>
                                                <th>Syndromes</th>
                                                <th>Probable viral agents</th>
                                                <th>Specimens</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>Respiratory syndrome</td>
                                                <td>Adenoviruses, Enteroviruses, Influenza virus, Parainfluenza virus, Respiratory syncytial virus (RSV), Rhinoviruses</td>
                                                <td>Throat swab, nasopharyngeal aspirate (NPA)</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Dermatological and mucous membrane disease</strong></td>
                                                <td></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>(i) Vesicular (hand-foot and mouth syndrome)</td>
                                                <td>Enterovirus, Herpes simplex, Varicella-zoster</td>
                                                <td>Stool, NPA, vesicle fluid or scraping</td>
                                            </tr>
                                            <tr>
                                                <td>(ii) Exanthematous</td>
                                                <td>Enterovirus, Measles, Rubella, Parvovirus</td>
                                                <td>Stool, NPA, Serum</td>
                                            </tr>
                                            <tr>
                                                <td>CNS infections</td>
                                                <td>Arboviruses, Enteroviruses, Herpes simplex, Mumps virus</td>
                                                <td>Stool, CSF, NPA</td>
                                            </tr>
                                            <tr>
                                                <td>Gastrointestinal</td>
                                                <td>Adenoviruses, Rotavirus</td>
                                                <td>Stool</td>
                                            </tr>
                                            <tr>
                                                <td>Congenital and perinatal</td>
                                                <td>Cytomegalovirus, Enterovirus, Herpes simplex virus</td>
                                                <td>Urine, NPA, CSF, blood</td>
                                            </tr>
                                            <tr>
                                                <td>Eye syndrome</td>
                                                <td>Adenoviruses, Herpes simplex virus, Vaccinia virus, Varicella-zoster virus, (Chlamydiae)</td>
                                                <td>Conjunctival swab or scraping, NPA</td>
                                            </tr>
                                            <tr>
                                                <td>CMV infection</td>
                                                <td>Cytomegalovirus (CMV)</td>
                                                <td>Urine, NPA, blood</td>
                                            </tr>
                                            <tr>
                                                <td>Myocarditis, pericarditis</td>
                                                <td>Coxsackie B</td>
                                                <td>Stool, NPA, pericardial fluid</td>
                                            </tr>
                                            <tr>
                                                <td>Hepatitis</td>
                                                <td>Hepatitis A, B, C, D and E viruses, CMV/Epstein Barr virus</td>
                                                <td>Stool, serum (except for A and E) Serum</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: introduction -->

                    <!-- START: transport-storage -->
                    <section class="content-section" id="transport-storage">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üßä</span>
                                Transport and Storage of Specimens
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Specimens for viral diagnosis must be considered infectious and should be handled with great care. Regulations for postage and transport must be fully observed. Within the laboratory, the specimens should be handled only in safety cabinets without releasing aerosols. Every virus isolation specimen should be treated as urgent and transported to the virus laboratory without delay. If it is unavoidable to wait for a transport, the specimen in a transport medium should be kept at 4¬∞C, but not at 0¬∞C or in an ice-box.</p>
                            <p>Care must be taken during transport and storage of specimens that the virus in the specimen should survive. Factors which can destroy viruses are dehydration, heat, freezing at temperatures near 0¬∞C, sudden pH changes, oxidising agents and ultraviolet light.</p>
                            <p>Aspirates, fluids and tissues should be sent to the laboratory in a sterile, leak-proof container. Swabs should never be left to dry and should be placed in VTM immediately.</p>
                            <p>When received in the laboratory, the specimens should be refrigerated (4¬∞C) until they are inoculated into cell cultures. A specimen may be kept at 4¬∞C for up to 96 hours. If the delay is longer, it should be stored at ‚Äì70¬∞C. Specimens expected to contain viruses such as enteroviruses, adenoviruses, or pox viruses should be stored at ‚Äì20¬∞C.</p>
                        </div>
                    </section>
                    <!-- END: transport-storage -->

                    <!-- START: diagnostic-methods -->
                    <section class="content-section" id="diagnostic-methods">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üî¨</span>
                                Diagnostic Methods Overview
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>There are several methods by which viral disease can be diagnosed in a clinical laboratory. These laboratory procedures can be divided into three categories:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">
                                        <strong>I. Direct methods</strong><br>
                                        Direct methods of viral diagnosis are based on
                                        <ol class="enhanced-list" style="margin-top: 0.5rem;">
                                            <li class="list-item">
                                                <span class="list-marker"></span>
                                                <span class="list-content">Detection of virus particles, viral antigen or viral nucleic acid in clinical specimens</span>
                                            </li>
                                            <li class="list-item">
                                                <span class="list-marker"></span>
                                                <span class="list-content">Detection of characteristic changes in the tissues or cells at the site of infection.</span>
                                            </li>
                                        </ol>
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>II. Isolation and identification of the causative agent</strong><br>
                                    Isolation of the infecting virus from appropriate specimens and its identification can establish diagnosis.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>III. Serological diagnosis</strong><br>
                                    Detection of specific viral antibodies and their quantitation at various stages of the disease is an important tool for the diagnosis of many viral diseases.</span>
                                </li>
                            </ol>
                        </div>
                    </section>
                    <!-- END: diagnostic-methods -->

                    <!-- START: direct-methods -->
                    <section class="content-section" id="direct-methods">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üîç</span>
                                Direct Methods for Detection of Viruses
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Direct detection of viruses, including their antigens or nucleic acids in clinical specimens provides rapid diagnosis of some viral diseases, and can be done in various ways:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Detection of virus inclusion bodies or free virus particles of large viruses, by examination of cells from inflammatory exudate by light or fluorescent microscopy.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Demonstration of virus particles in the specimen by electron microscopy.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Detection of viral antigens by immunological methods.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Demonstration of virus specific DNA or RNA in cellular exudate extracts by nucleic acid hybridization techniques.</span>
                                </li>
                            </ol>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìë</span>
                                    <span class="table-caption">Table 3.2 Direct methods for virus diagnosis</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table comparison-table">
                                        <thead>
                                            <tr>
                                                <th>Suspected virus group</th>
                                                <th>Microscopy</th>
                                                <th>Immunological methods</th>
                                                <th>Others</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>Herpes simplex virus</td>
                                                <td>Inclusion bodies, EM</td>
                                                <td>IF, ELISA, RIA</td>
                                                <td>NAH</td>
                                            </tr>
                                            <tr>
                                                <td>Poxvirus</td>
                                                <td>Inclusion bodies, EM</td>
                                                <td>Gel diffusion, CF</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Molluscum contagiosum virus</td>
                                                <td>Inclusion bodies, EM</td>
                                                <td>-</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Influenza virus</td>
                                                <td>-</td>
                                                <td>IF, ELISA</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Parainfluenza virus</td>
                                                <td>-</td>
                                                <td>IF</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Respiratory syncytial virus (RSV)</td>
                                                <td>-</td>
                                                <td>IF, ELISA, RIA</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Adenovirus</td>
                                                <td>-</td>
                                                <td>IF, ELISA, RIA</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Cytomegalovirus (CMV)</td>
                                                <td>Inclusion bodies</td>
                                                <td>IF, ELISA, RIA</td>
                                                <td>NAH</td>
                                            </tr>
                                            <tr>
                                                <td>Measles virus</td>
                                                <td>Inclusion bodies</td>
                                                <td>IF, ELISA</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Rotavirus</td>
                                                <td>EM</td>
                                                <td>ELISA</td>
                                                <td>NAH</td>
                                            </tr>
                                            <tr>
                                                <td>Adenovirus</td>
                                                <td>EM</td>
                                                <td>ELISA</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Hepatitis A virus</td>
                                                <td>EM</td>
                                                <td>-</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Hepatitis B virus</td>
                                                <td>EM</td>
                                                <td>-</td>
                                                <td>Serological diagnosis</td>
                                            </tr>
                                            <tr>
                                                <td>Poliovirus</td>
                                                <td>-</td>
                                                <td>-</td>
                                                <td>Culture and serological diagnosis</td>
                                            </tr>
                                            <tr>
                                                <td>Mumps virus</td>
                                                <td>-</td>
                                                <td>-</td>
                                                <td>-</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                            <p class="figure-caption">Key: EM ‚Äì Electron microscopy; IF ‚Äì immunofluorescence; ELISA ‚Äì Enzyme linked immunosorbent assay; RIA: radioimmunoassay; CF ‚Äì complement fixation; NAH ‚Äì nucleic acid hybridization</p>

                            <h3 id="light-microscopy">1. Use of Light Microscopy for Viral Diagnosis</h3>
                            <p>Viruses with the exception of the poxvirus group, are too small to be seen with even the highest magnification of the conventional light microscope. Poxviruses can be seen as eosinophilic featureless dust-like particles, lying extra-cellularly in the scrapings from the base of the vesicular lesions, in appropriately stained specimens. The viruses can be directly demonstrated as inclusion bodies in infected tissues and smears by light microscopy. Inclusion bodies are structures with distinct size, shape, location and staining properties. These are the sites of virus replication. As a general rule, viruses that assemble in the cytoplasm form intracytoplasmic inclusions, whereas those that assemble in the nucleus yield intranuclear inclusions. Inclusion bodies can be seen by staining methods such as Giemsa, Machiavello and Castaneda, haematoxylin and eosin or Papanicolaou methods. Fluorochromes such as acridine orange give very good results with viral nucleic acids when observed under fluorescent microscope.</p>

                            <h4>Giemsa staining for inclusion bodies</h4>
                            <p><strong>Intranuclear inclusion</strong> These can be observed in cells that have been infected by herpes simplex virus, varicella-zoster virus, cytomegalovirus, adenovirus and papovaviruses. The inclusion of herpes simplex and varicella-zoster appear similar and show a homogeneous, eosinophilic or slightly basophilic material in the nucleus. Nuclear chromatin, which is basophilic, is pushed against the edge of the nuclear membrane. The infected cells may be mononuclear or multinuclear. Cytomegalovirus produces basophilic nuclear inclusions in an enlarged cell. A clear halo is often observed around the inclusion. Adenoviruses produce a variety of inclusions. In early stages, the inclusions are eosinophilic which become basophilic as they mature, and fill the nucleus. Eventually they become intensely basophilic and may completely distort the cell. These characteristic cells are called smudge cells. Intranuclear inclusions of papova virus in human warts begin as a granular eosinophilic matter and later condense into rounded basophilic masses.</p>
                            <p><strong>Intracytoplasmic inclusions</strong> These may be seen in cells infected with respiratory syncytial virus (RSV), rabies virus and poxvirus group. RSV produces brightly eosinophilic intracytoplasmic inclusions. Negri bodies, the intracytoplasmic inclusions of rabies virus, occur as eosinophilic masses in the cytoplasm of nerve cells. The edges of the inclusion are sharply demarcated. Vaccinia infected cells show rather small multiple inclusions called Guarnieri bodies. Inclusion bodies in molluscum contagiosum are very large eosinophilic bodies (20‚Äì30Œºm) which can be easily seen even under the low power of the microscope.</p>
                            <p>Measles virus produces both intracytoplasmic and intranuclear inclusions in the giant cells formed in the epithelial tissue. These are very large, multinucleated cells and show eosinophilic intranuclear inclusions similar to those produced by Herpes simplex virus. In addition, measles infected cells also contain brightly eosinophilic intracytoplasmic inclusions.</p>

                            <h4>Fluorochrome staining for inclusion bodies</h4>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Fix the smear in 25% acetic acid (v/v) in methanol.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Prepare a 1 in 2000 to 1 in 4000 solution of acridine orange in acetate buffer, pH 3.0.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Flood the smear with the stain for 10 minutes.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Wash and mount in acetate buffer, pH 3. Examine in ultraviolet light.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Intranuclear or intracytoplasmic inclusion bodies exhibit fluorescence with various shades of green.</span>
                                </li>
                            </ol>

                            <h3 id="electron-microscopy">2. Electron Microscopy (EM)</h3>
                            <p>A much higher magnification than that obtained by light microscopy is available by electron microscopy. All viruses can be seen by EM. However, an electron microscope is an expensive instrument which is not available in most laboratories. When available, it can be used to identify viruses in pathological specimens, biopsies and laboratory tissue cultures. Viruses can be detected in two ways, by direct method or by immune electron microscopy (IEM).</p>
                            <p>The material to be examined is suspended and centrifuged at low speed (300g for 10 minutes) to get rid of the debris. The supernatant can contain sufficient virus for EM preparations. This supernatant is centrifuged at high speed (e.g. 20,000g for 10 minutes) to concentrate the virus in the pellet. The concentrated virus is then transferred to a grid for EM. Grids for EM are made of copper and must be coated with a carbon film before use. The grid should be placed on a filter paper before transferring the material on to it. Alternatively, the clarified clinical material may be spun on to a grid placed at the bottom of the centrifuge tube. The grid is then air-dried.</p>
                            <p>Staining of virus particles is done by a negative staining method using salts of heavy metals such as uranyl acetate or phosphotungstic acid. This electron-dense material causes shadowing of the viruses present on the specimen grid which makes unstained virus particles stand out.</p>

                            <h4>Direct method</h4>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Place drops of the staining solution on a sheet of parafilm.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">The grid is floated upside down on the solution.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">After the appropriate staining time, the grid is washed thrice by floating it on distilled water and subsequently air-dried on a filter paper. Watmaker's tweezers are used to manipulate the grids.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">The grid is then placed in the electron microscope and scanned for virus particles.</span>
                                </li>
                            </ol>
                            <p>The EM can be used for the detection of virus particles from materials such as vesicular exudates from herpesvirus or poxvirus lesions, serum for hepatitis B virus or faecal extracts for rotavirus, Norwalk virus and poliovirus.</p>
                            <p>The diagnosis made by EM is morphological, based on the appearance of the virus particles. Since viruses from a group have the same morphology, it is not possible to identify them separately, and they cannot be typed by EM. For example, all adenoviruses look alike irrespective of their serotype or pathogenicity. The procedure for quantitation of virus particles by EM is very cumbersome and not very accurate. However, it has a great advantage over light microscopy in that both intra or extracellular particles may be visualised by EM whereas intact cells are required for the detection of inclusion bodies by light microscopy. It is also useful for the detection of non-cultivable viruses.</p>

                            <div class="grid grid-3">
                                <div class="grid-item">
                                    <figure class="content-figure" data-lightbox="true">
                                        <div class="figure-image-wrapper">
                                            <img src="../assets/images/image-20251219-852125d2.jpeg" 
                                                 alt="Electron micrograph of Rabies virus" 
                                                 class="figure-image"
                                                 loading="lazy">
                                            <div class="figure-overlay">
                                                <span class="overlay-icon">üîç</span>
                                            </div>
                                        </div>
                                        <figcaption class="figure-caption">Fig. 3.1a Electron micrograph of Rabies virus</figcaption>
                                    </figure>
                                </div>
                                <div class="grid-item">
                                    <figure class="content-figure" data-lightbox="true">
                                        <div class="figure-image-wrapper">
                                            <img src="../assets/images/image-20251219-f22df651.jpeg" 
                                                 alt="Electron micrograph of adenovirus" 
                                                 class="figure-image"
                                                 loading="lazy">
                                            <div class="figure-overlay">
                                                <span class="overlay-icon">üîç</span>
                                            </div>
                                        </div>
                                        <figcaption class="figure-caption">Fig. 3.1b Electron micrograph of adenovirus</figcaption>
                                    </figure>
                                </div>
                                <div class="grid-item">
                                    <figure class="content-figure" data-lightbox="true">
                                        <div class="figure-image-wrapper">
                                            <img src="../assets/images/image-20251219-89a701ad.jpeg" 
                                                 alt="Electron micrograph of hepatitis B (three forms) virus" 
                                                 class="figure-image"
                                                 loading="lazy">
                                            <div class="figure-overlay">
                                                <span class="overlay-icon">üîç</span>
                                            </div>
                                        </div>
                                        <figcaption class="figure-caption">Fig. 3.1c Electron micrograph of hepatitis B (three forms) virus</figcaption>
                                    </figure>
                                </div>
                            </div>

                            <h4>Immune Electron Microscopy (IEM)</h4>
                            <p>Immunological specificity may be added to EM identification in a number of situations. Pre-mixing the virus in a suspension with a homologous antibody usually causes the clumping of virus particles which are then more easily detected. This method is more sensitive than the direct method for EM.</p>
                            
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Add the antiserum to a small volume of the specimen and incubate for 1‚Äì2 hours at 37¬∞C. Spin on the grid at 20,000g for 10 minutes. Alternatively, the grid may be coated with the antiserum and then allowed to float on the surface of the specimen for 30‚Äì60 minutes at room temperature.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">The grid is then air-dried and examined by EM. Virus particles aggregated by the antiserum are more easily seen than by direct microscopy.</span>
                                </li>
                            </ol>
                            <p>IEM is less useful with virus groups which have a large number of serotypes, such as enteroviruses. It is possible to detect only one serotype at a time.</p>

                            <h3 id="immunological-methods">3. Detection of Viral Antigens by Immunological Methods</h3>
                            <p>Immunological techniques have been effectively used for the detection of certain viral antigens in tissues, exudates or culture cells. It is useful for identification of hepatitis A virus and rotavirus by direct examination of faecal specimens, because these viruses are not readily grown in cell-cultures.</p>
                            <p>Four types of immunoassays are commonly used for the viral antigen detection.</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Immunofluorescence test (IFT)</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Enzyme-linked immunosorbent assay (ELISA or EIA)</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Radioimmunoassay (RIA)</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Immunoperoxidase staining</span>
                                </li>
                            </ol>

                            <h4>(i) Immunofluorescence tests (IFT)</h4>
                            <p>The IFT can be performed by two methods, direct and indirect.</p>
                            <p><strong>Direct Test:</strong> Specific antiserum is conjugated with fluorescein isothiocyanate and allowed to react with the specimen. The presence of antigen is detected by fluorescence when observed under a fluorescence microscope.</p>
                            <p><strong>Indirect Test:</strong> Unconjugated known specific antiserum is allowed to react with the specimen. The antigen is detected by adding anti-immunoglobulin conjugated with fluorescein isothiocyanate, which binds to the antibody.</p>

                            <h4>(ii) Enzyme-linked immunosorbent assay (ELISA)</h4>
                            <p>Two ELISA techniques can be used for antigen detection.</p>
                            <p><strong>(a) Sandwich Method</strong> Specific antibody is coated on a solid phase such as a microtitre plate. The antigen in the specimen is captured by the antibody. After washing, the captured antigen is spotted by the same antibody linked to an enzyme. After washing off the excess, presence of enzyme-labeled antibody can be detected by adding the substrate to produce a coloured reaction.</p>
                            <p><strong>(b) Competition method</strong> To a microtitre plate coated with specific antibody against the suspected antigen, a mixture of the known antigen labeled with enzyme (E) and an extract from a clinical material is added.</p>
                            <p>On addition of a specific substrate, the labelled antigen produces a colour reaction. If the antigen is present in the clinical specimen it can block some antibody combining sites, thus competing with the labeled antigen. The amount of antigen in the specimen is inversely proportional to the colour intensity.</p>
                            <p>If there is no antigen in the clinical material (unlabeled), all the antibody sites are occupied by the labeled antigen giving a strong colour reaction. This is a negative result. In Fig. 3.2, the clinical specimen contains antigen which attaches to the antibody, leaving little or no space for the labelled antigen. In this case, colour reaction is weak or absent. This is a positive test result.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-8a4c5d80.jpeg" 
                                         alt="Diagram showing Competition method for the detection of antigen by ELISA" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 3.2 Competition method for the detection of antigen by ELISA</figcaption>
                            </figure>

                            <h4>(iii) Radioimmunoassay (RIA) for virus detection</h4>
                            <p>The RIA is based on the same principles as the ELISA, except that a radio-labelled antibody or antigen is used instead of an enzyme-linked antibody. The radioactive label most commonly used is $^{125}\mathrm{I}$.</p>
                            <p>The underlying principle of RIA is to select the most appropriate proportion of the radio-labelled antigen and its specific antibody so that they remain in a state of equilibrium. The equilibrium of this standard is then disturbed by adding the unlabelled antigen. A standard curve is obtained by measuring the radioactivity of varying known quantities of unlabelled antigen which competes with the labelled antigen for antibody sites. The concentration of viral antigen in the test sample can be determined by computing the resultant radioactivity from the standard curve.</p>
                            <p>The RIA test, though very sensitive, is used less commonly because of the restrictions imposed on work with radioactive substances. In most cases an ELISA can be used instead of RIA for the same information at lower cost and at less risk for the workers.</p>

                            <h4>(iv) Immunoperoxidase staining</h4>
                            <p>The principle of immunoperoxidase staining is identical with that of direct immunofluorescence test except that the antiserum is labelled with an enzyme instead of fluorescein.</p>
                            <p>The clinical specimen is smeared on the slide, dried and fixed in acetone for 10 minutes. The enzyme-labelled specific antibody is allowed to react with the viral antigen in the smear. After washing, the enzyme substrate is added. A colour change is produced due to the action of the enzyme on the substrate. This change can be read macro- and microscopically.</p>

                            <h3 id="nucleic-acid-hybridization">4. Nucleic Acid Hybridization</h3>
                            <p>Cells infected by viruses contain large amounts of viral nucleic acid, either DNA or RNA. The nucleotide sequences of a particular virus or a group of related viruses are unique. Therefore their detection offers a highly specific test for the presence of viruses.</p>
                            <p>The nucleic acid hybridization technique involves the use of nucleic acid probes. DNA consists of a double helix of two nucleotide chains with complementary bases that pair with one another, guanine with cytosine and adenine with thymine. By application of heat or in the presence of an alkali, this base pairing is broken and the two strands of DNA are separated. On removal of the denaturing conditions, the two strands with a complementary base sequence reunite or reanneal in a highly specific manner.</p>
                            <p>The basis of the nucleic acid hybridization or probe detection technique is the formation of duplexes between a nucleotide chain of the known viral origin, (the probe), and the chains of the same or similar base pairing (homology) in the clinical material. Thus, if a known DNA is denatured in solution and another species of DNA or RNA is mixed with it, mixed hybrids or duplexes may form between the nucleotide chains of the first and the second DNA or RNA, under appropriate conditions. At the same time, however, some complementary chains of the original DNA will also reassociate and reanneal and compete with the new duplex or mixed strands.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-8afd94db.jpeg" 
                                         alt="Diagram of Sandwich hybridization on filters" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 3.3 Sandwich hybridization on filters</figcaption>
                            </figure>

                            <h4>Polymerase chain reaction (PCR)</h4>
                            <p>PCR is the best studied amplification technique since its inception in 1985. The method is an in vitro assay in which specific nucleic acid sequences are amplified. Double stranded target DNA is denatured by heat in the presence of two oligonucleotide primers. These primers flank the sequences to be amplified and they are complementary to opposite strands. DNA synthesis is repeated in cycles to perform in vitro replication of target nucleic acid sequences.</p>
                            <p>Each cycle of PCR comprises three stages:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Stage 1:</strong> Target DNA is denatured by heating at 94¬∞C. This causes the target DNA strands to separate and made acceptable for hybridization by specific oligonucleotide primers.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Stage 2:</strong> At reduced temperature (40‚Äì60¬∞C), the primers anneal to their complimentary target strands in a sequence in a specific manner.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Stage 3:</strong> The primers are extended on the DNA template by a DNA polymerase at a temperature of 73¬∞C, and two short lengths of double stranded DNA are generated.</span>
                                </li>
                            </ul>
                            <p>Thus, after each cycle of PCR, there are two double strands identical to the original one. Each extension product (new double strands) and the original one can serve as templates in second round of primer annealing and extension. As the number increases exponentially, thirty thermal cycles which take less than two hours, are sufficient to generate up to one billion copies of the original target DNA. The last step of PCR assay is the detection of amplified DNA. This is done by gel electrophoresis or hybridization to a specific probe.</p>
                        </div>
                    </section>
                    <!-- END: direct-methods -->

                    <!-- START: isolation-identification -->
                    <section class="content-section" id="isolation-identification">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß´</span>
                                Isolation and Identification of Viral Agents
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Isolation of infecting virus in cell culture is the most sensitive method of diagnosing viral diseases. Some viruses are unable to proliferate in cell cultures. Such viruses may be cultivated in other alternative systems such as animals or embryonated eggs. Cultivation of viruses in various systems is described in Chapter 2.</p>

                            <h3 id="processing-specimens">Processing Specimens for Inoculation</h3>
                            <p>Clinical specimens need to be processed before they are inoculated into cell cultures. Turbid specimens are clarified by centrifugation. Antibiotic solutions may be added to prevent bacterial contamination. The procedure varies according to specimen. General guidelines are provided below.</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Swabs (throat, nasal, genital or from lesions):</strong> Swabs are received in the transport medium. If not, place the swab in 3‚Äì4 ml of viral transport medium (VTM). Mix on a vortex mixer for 30 seconds. Press the swab against the wall of the container to express the fluid. Discard the swab. Centrifuge the fluid at 1500 g for 10 min. Use the clear supernatant fluid to inoculate cell cultures.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>CSF and other body fluids:</strong> Clear specimen does not need any processing. Centrifuge turbid specimens at 1500 g for 10 minutes. Use the supernatant to inoculate the cell culture.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Urine:</strong> Transfer 10 ml of the specimen to a sterile centrifuge tube. Add 0.05 ml of 50 Œºg/ml gentamicin and 0.05 ml of 250 Œºg/ml of amphotericin B. Mix well and incubate at room temperature for 30‚Äì45 minutes. Centrifuge at 1500 g for 10 min. Decant the supernatant into another sterile container. Use the supernatant to inoculate the cell cultures except the diploid fibroblast cultures. Vortex the deposit in the centrifuge tube and use it for inoculating the diploid fibroblast cultures.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Faeces:</strong> Mix a pea-sized portion of the specimen in about 3‚Äì4 ml of VTM and spin at 1500 g for 10 minutes. Filter the supernatant through 0.45 Œºm pore-size sterile filter. Syringe-top filters are convenient to use. Inoculate the cell cultures with the filtered fluid. Follow the same procedures of centrifugation and filtration for the rectal swabs in VTM.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Tissue:</strong> Grind the tissue in 3‚Äì4 ml of VTM in a sterile grinder. Centrifuge the ground tissue in VTM at 1500 g for 10 mins. If the supernatant is still turbid, filter it through 0.45 Œºm filter. Use the clear fluid for inoculation.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Anticoagulated blood:</strong> Use mononuclear cells in blood as the inoculum for cell cultures. These cells can be separated by centrifugating the blood over a mixture of Ficoll and Hypaque. After centrifugation, red blood cells and polymorphs settle at the bottom of the tube, leaving the mononuclear cells at the junction of the Ficoll-Hypaque mixture and the blood plasma. Harvest the mononuclear cells carefully for inoculation.</span>
                                </li>
                            </ul>

                            <h3 id="detection-viral-growth">Detection of Viral Growth in Cell Cultures</h3>
                            <p>Many viruses produce degenerative changes in the cell monolayer during their proliferation. These changes can be observed microscopically. However, some viruses do not produce any change that can be detected microscopically. Other methods of detection are necessary for such viruses.</p>
                            <p>The methods commonly used for the detection of viral proliferation in cell cultures include:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Cytopathic effect (CPE)</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Haemagglutination</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Haemadsorption</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Interference challenge</span>
                                </li>
                            </ol>

                            <h4>1. Cytopathic effect</h4>
                            <p>When a virus grows in a cell monolayer, it may bring about destruction of cells, thereby changing the appearance of the monolayer. This change or destruction is called cytopathic effect (CPE). It is characteristic for an individual virus or a group of viruses. Many types of CPE can be seen in unstained cell monolayers, while some types are seen only in stained preparations. The CPE usually starts as a focus or multiple foci. It later spreads all over the monolayer. The rate and pattern of CPE depends upon:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">The type of cell monolayer.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">The properties of the infecting virus.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">The concentration of the virus in the specimen.</span>
                                </li>
                            </ol>

                            <div class="grid grid-3">
                                <div class="grid-item">
                                    <figure class="content-figure" data-lightbox="true">
                                        <div class="figure-image-wrapper">
                                            <img src="../assets/images/image-20251219-fd202417.jpeg" 
                                                 alt="Normal HE-2 monolayer" 
                                                 class="figure-image"
                                                 loading="lazy">
                                            <div class="figure-overlay">
                                                <span class="overlay-icon">üîç</span>
                                            </div>
                                        </div>
                                        <figcaption class="figure-caption">Fig 3.4a Normal HE-2 monolayer</figcaption>
                                    </figure>
                                </div>
                                <div class="grid-item">
                                    <figure class="content-figure" data-lightbox="true">
                                        <div class="figure-image-wrapper">
                                            <img src="../assets/images/image-20251219-abc313ed.jpeg" 
                                                 alt="CPE due to infection with adenovirus" 
                                                 class="figure-image"
                                                 loading="lazy">
                                            <div class="figure-overlay">
                                                <span class="overlay-icon">üîç</span>
                                            </div>
                                        </div>
                                        <figcaption class="figure-caption">Fig 3.4 b (i) CPE due to infection with adenovirus</figcaption>
                                    </figure>
                                </div>
                                <div class="grid-item">
                                    <figure class="content-figure" data-lightbox="true">
                                        <div class="figure-image-wrapper">
                                            <img src="../assets/images/image-20251219-a5ac5d58.jpeg" 
                                                 alt="CPE due to infection with respiratory syncytial virus" 
                                                 class="figure-image"
                                                 loading="lazy">
                                            <div class="figure-overlay">
                                                <span class="overlay-icon">üîç</span>
                                            </div>
                                        </div>
                                        <figcaption class="figure-caption">Fig. 3.4b (ii) CPE due to infection with respiratory syncytial virus</figcaption>
                                    </figure>
                                </div>
                            </div>

                            <h4>2. Haemagglutination</h4>
                            <p>Some viruses have surface projections or spikes for which erythrocytes possess complementary receptor sites. Such viruses, when mixed with appropriate erythrocytes, are capable of binding them. This binding produces visible agglutination and is known as viral haemagglutination. The viral surface projections are proteins and are called haemagglutinins. The receptor sites on erythrocytes are not immunoglobulins and therefore, viral haemagglutination is not an antigen-antibody reaction.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-982c1296.jpeg" 
                                         alt="The pattern of haemagglutination" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 3.5 The pattern of haemagglutination</figcaption>
                            </figure>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-5c8cd296.jpeg" 
                                         alt="Haemagglutination test" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 3.6 Haemagglutination test</figcaption>
                            </figure>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-caption">Table 3.3 Methods of cultivation and identification of viruses</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table comparison-table">
                                        <thead>
                                            <tr>
                                                <th>Virus</th>
                                                <th>Primary isolation in PMK</th>
                                                <th>HEP2</th>
                                                <th>HDF</th>
                                                <th>Rate of growth (days)</th>
                                                <th>CPE</th>
                                                <th>Confirmatory tests</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>Influenza</td>
                                                <td>+</td>
                                                <td>-</td>
                                                <td>-</td>
                                                <td>2-10</td>
                                                <td>None or degeneration with swollen, vacuolated cells</td>
                                                <td>HAI, IF, CF</td>
                                            </tr>
                                            <tr>
                                                <td>Parainfluenza</td>
                                                <td>+</td>
                                                <td>+</td>
                                                <td>-</td>
                                                <td>4-10</td>
                                                <td>None or focal rounding and multinucleated giant cells</td>
                                                <td>HAI, IF, CF</td>
                                            </tr>
                                            <tr>
                                                <td>Respiratory syncytial virus (RSV)</td>
                                                <td>+</td>
                                                <td>+</td>
                                                <td>+</td>
                                                <td>3-10</td>
                                                <td>Syncytia in PMK and HEP-1. Focal degeneration in HDF</td>
                                                <td>IF, NT, ELISA</td>
                                            </tr>
                                            <tr>
                                                <td>Mumps virus</td>
                                                <td>+</td>
                                                <td>¬±</td>
                                                <td>¬±</td>
                                                <td>5-10</td>
                                                <td>Usually absent, large syncytia may be seen</td>
                                                <td>HAI, NT</td>
                                            </tr>
                                            <tr>
                                                <td>Measles virus</td>
                                                <td>+</td>
                                                <td>+</td>
                                                <td>-</td>
                                                <td>-</td>
                                                <td>Rarely isolated, may show vacuolated syncytia</td>
                                                <td>NT, IF</td>
                                            </tr>
                                            <tr>
                                                <td>Pohovirus</td>
                                                <td>+</td>
                                                <td>+</td>
                                                <td>+</td>
                                                <td>2-8</td>
                                                <td>Swollen, refractile cells, rapid progression to the entire monolayer, cells detached</td>
                                                <td>IF, NT, ELISA</td>
                                            </tr>
                                            <tr>
                                                <td>Coxsackie B virus</td>
                                                <td>+</td>
                                                <td>+</td>
                                                <td>-</td>
                                                <td>2-8</td>
                                                <td></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>Echovirus</td>
                                                <td>+</td>
                                                <td>-</td>
                                                <td>+</td>
                                                <td>2-8</td>
                                                <td></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>Adenovirus</td>
                                                <td>+</td>
                                                <td>+</td>
                                                <td>¬±</td>
                                                <td>2-10</td>
                                                <td>Rounded cells in grape-like clusters</td>
                                                <td>NT, IF, CF</td>
                                            </tr>
                                            <tr>
                                                <td>Herpes simplex virus</td>
                                                <td>¬±</td>
                                                <td>+</td>
                                                <td>+</td>
                                                <td>1-3</td>
                                                <td>Rounded, swollen cells, occasional syncytia, rapid destruction of the entire monolayer</td>
                                                <td>IF, ELISA</td>
                                            </tr>
                                            <tr>
                                                <td>Cytomegalovirus</td>
                                                <td>-</td>
                                                <td>-</td>
                                                <td>+</td>
                                                <td>5-21</td>
                                                <td>Distinct foci of enlarged cells, slow progression</td>
                                                <td>IF, H&E</td>
                                            </tr>
                                            <tr>
                                                <td>Varicella-zoster virus</td>
                                                <td>¬±</td>
                                                <td>-</td>
                                                <td>+</td>
                                                <td>4-10</td>
                                                <td>Discrete, elongated foci of enlarged or shrunken cells</td>
                                                <td>IF, CF</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h3 id="identification-viral-isolates">Identification of Viral Isolates</h3>
                            <p>There are many methods available for the identification of a virus isolated from a clinical specimen. Most of these methods use a known specific antibody to identify an unknown isolate. The same methods can also be modified for the direct identification of a viral antigen in a clinical specimen; or can be reversed and used for the detection of unknown antibodies with the help of known viral antigens.</p>
                            <p>The tests most commonly used for the identification of viral isolates are:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Neutralization tests</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Immunofluorescence (IF) test</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Enzyme-linked immunosorbent assay (ELISA or EIA)</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Complement fixation test (CFT)</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Nucleic acid hybridization test.</span>
                                </li>
                            </ol>

                            <h4>Neutralization tests</h4>
                            <p>A virus binds with a corresponding specific antibody and becomes 'neutralized' i.e. it becomes non-infectious due to the blockage of critical sites by antibody molecules. When a neutralized virus is tested by a virus detection system, such as CPE in a cell monolayer or haemagglutination, the characteristic evidence of its presence does not appear. The absence of evidence establishes the identity of the infecting virus.</p>
                            <p>Two types of neutralization tests are commonly used for virus identification:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Neutralization of CPE of cytopathogenic viruses</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Haemagglutination inhibition test</span>
                                </li>
                            </ol>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-1afcb6cd.jpeg" 
                                         alt="Principle of viral haemagglutination inhibition (Part 1)" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 3.7 Principle of viral haemagglutination inhibition</figcaption>
                            </figure>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-054d27ae.jpeg" 
                                         alt="Principle of viral haemagglutination inhibition (Part 2)" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                    </div>
                                </div>
                            </figure>
                        </div>
                    </section>
                    <!-- END: isolation-identification -->

                    <!-- START: serodiagnosis -->
                    <section class="content-section" id="serodiagnosis">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíâ</span>
                                Serodiagnosis of Viral Infections
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Serodiagnosis of viral infections involves detection of antibodies to viral antigens in patient‚Äôs serum in sufficiently high titres.</p>
                            <p>The procedures commonly used for serological diagnosis of viral infections include the following.</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Indirect immunofluorescence (IF) test</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Enzyme linked immunosorbent assay (ELISA) or enzyme immunoassay (EIA)</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Neutralization (NT) test</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Complement fixation (CF) test.</span>
                                </li>
                            </ol>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-caption">Table 3.5 Serological tests for diagnosis of viral infections</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table comparison-table">
                                        <thead>
                                            <tr>
                                                <th>Virus</th>
                                                <th>Tests performed</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td><strong>Respiratory Infections</strong></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>Influenza A and B</td>
                                                <td>CF; HAI</td>
                                            </tr>
                                            <tr>
                                                <td>Parainfluenza virus</td>
                                                <td>HAI; CF; ELISA</td>
                                            </tr>
                                            <tr>
                                                <td>Respiratory syncytial virus</td>
                                                <td>CF; ELISA</td>
                                            </tr>
                                            <tr>
                                                <td>Adenovirus</td>
                                                <td>CF; ELISA</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Central Nervous System Infections</strong></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>Enteroviruses</td>
                                                <td>CF; NT; ELISA</td>
                                            </tr>
                                            <tr>
                                                <td>Mumps virus</td>
                                                <td>HAI; IF; ELISA</td>
                                            </tr>
                                            <tr>
                                                <td>Herpes simplex virus</td>
                                                <td>CF; ELISA; IF</td>
                                            </tr>
                                            <tr>
                                                <td>Rabies virus</td>
                                                <td>IF</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Hepatitis</strong></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>Hepatitis A</td>
                                                <td>RIA; ELISA</td>
                                            </tr>
                                            <tr>
                                                <td>Hepatitis B</td>
                                                <td>RIA; ELISA</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Cutaneous Infections</strong></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>Measles virus</td>
                                                <td>HAI; IF; ELISA; CF</td>
                                            </tr>
                                            <tr>
                                                <td>Varicellazoster virus</td>
                                                <td>CF; IF</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Other Infections</strong></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>Cytomegalovirus</td>
                                                <td>ELISA; CF; HAI; IF</td>
                                            </tr>
                                            <tr>
                                                <td>Rubella</td>
                                                <td>HAI; ELISA; IF; Heterophile test.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Epstein-Barr virus</strong></td>
                                                <td>ELISA</td>
                                            </tr>
                                            <tr>
                                                <td>HIV (AIDS)</td>
                                                <td>Immunodot assays, ELISA, IF, Western blot assay</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h3 id="interpretation-serological-tests">Interpretation of Viral Serological Tests</h3>
                            <p>Application of principles of immunology is necessary for establishing a diagnosis of viral disease with the help of serological methods. Antibodies to many viral antigens persist in the body for a very long period extending up to months or years after encounter with the antigen. Evidence of significant increase (four fold) in the titre of antibody in paired sera is considered diagnostic of recent infection with the viral agent. In some cases, antibodies may not be present initially in the acute phase serum, but may appear a few days later. This is known as seroconversion. In such cases, infection generally represents a primary encounter with the virus.</p>

                            <h4>Acute and convalescent phase sera</h4>
                            <p>Whenever a patient is suspected of suffering from a viral illness, a specimen of serum in acute phase should be collected and stored at ‚Äì70¬∞C. This is of great help if viral culture fails to isolate virus or if identification of the isolate is uncertain. Under these circumstances, a convalescent phase serum may be requested 2‚Äì3 weeks after the first specimen. Demonstration of a four fold rise in titre of any antibody in paired sera can establish the diagnosis.</p>

                            <h4>Single serum</h4>
                            <p>In some cases, a single serum sample may be examined and appropriately interpreted to reach a diagnosis. Determination of antibody titre of a particular immunoglobulin class to the suspected antigen can help in the identification of the causative agent and stage of the disease. In general, IgM antibody appears earlier than IgG. Presence of IgM antibody is of short duration, and therefore, suggests a recent or current infection. Virus specific IgM antibody usually rises during the first 2‚Äì3 weeks of infection and persists for some weeks to months, eventually being replaced with IgG antibody. Thus, a raised titre of specific IgM antibody suggests a recent primary infection by the virus, and a fall in IgM antibody in the follow up sera may further support it. For example, demonstration of IgM antibody to hepatitis A or B (core antigen) is the method of choice for establishing a recent or acute infection by these viruses.</p>
                            <p>Another important use of single serum is to screen neonates for certain antibodies of IgM class. IgG antibody can cross the placenta and enter passively into foetus circulation, but IgM cannot. Therefore, presence of IgG antibodies in an infant may be a result of passive transfer from mother to the foetus whereas IgM antibodies indicate active infection.</p>
                        </div>
                    </section>
                    <!-- END: serodiagnosis -->

                    <!-- Key Points Section -->
                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Key Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Isolation of infecting virus in cell culture is the most sensitive method of diagnosing viral diseases.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Demonstration of a four fold rise in titre of any antibody in paired sera can establish the diagnosis.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Specimens for viral diagnosis must be considered infectious and should be handled with great care.</strong></p>
                                </li>
                            </ul>
                        </div>
                    </aside>
                </main>

                <!-- BOTTOM NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-02-cultivation.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="topic-04-vaccines-antivirals.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 75%;"></div>
                        </div>
                        <span class="progress-text">Topic 3 of 4</span>
                    </div>
                </nav>

            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div id="lightbox" class="lightbox-modal" hidden aria-hidden="true" role="dialog" aria-label="Image viewer">
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>